IL-17, GAL-10, and TGF-β are promising noninvasive biomarkers of pediatric eosinophilic esophagitis

Pediatr Allergy Immunol. 2024 Mar;35(3):e14111. doi: 10.1111/pai.14111.

Authors

Martina Votto^{1

2}, Matteo Naso¹, Mara De Amici^{2

3}, Riccardo Castagnoli^{1

2}, Annalisa De Silvestri⁴, Maria De Filippo^{1

2}, Giorgia Testa², Gian Luigi Marseglia^{1

2}, Amelia Licari^{1

2}

Affiliations

¹ Pediatric Unit, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.
² Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
³ Laboratory of Immuno-Allergology of Clinical Chemistry, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
⁴ Biometry and Clinical Epidemiology, Scientific Direction, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

PMID: 38512103
DOI: 10.1111/pai.14111

No abstract available

MeSH terms

Child
Enteritis*
Eosinophilia*
Eosinophilic Esophagitis* / diagnosis
Gastritis*
Humans
Interleukin-17
Transforming Growth Factor beta

Substances

Interleukin-17
Transforming Growth Factor beta

Supplementary concepts

Eosinophilic enteropathy